2020 Vault Rankings
About IQVIA (formerly IMS Consulting Group)
IMS Consulting Group (IMSCG) is a major player in the field of global biotech and pharmaceutical management consulting. With around 500 consultants, the firm maintains a presence on five continents and focuses on partnering with clients in the pharmaceuticals, biotech and other life sciences sectors to help them make informed decisions. IMSCG has growing teams in the emerging markets, with strong local experts in Brazil, Shanghai, Singapore, and truly global project work offering teams broader exposure.
The company has four main centers of excellence: brand and commercial strategy, competitive intelligence, pricing and market access, and strategy and portfolio analysis. Altogether, those units offer clients end-to-end services, qualitative and quantitative analysis of existing and emerging market trends and thorough implementation and execution of those strategies.
A healthy outlook
If the IMS name seems familiar in the life sciences context, that's probably because IMS Consulting Group is a unit of IMS Health—one of the best-known providers of information services for the healthcare industry. Having long offered consulting as a service, the firm decided in 2011 to create a separate identity for its management consulting arm—and IMS Consulting Group is the result.
In addition to partnering with some of the biggest names in pharmaceuticals and biotech, IMSCG consultants also help non-profit organizations to work towards their goals in designing and delivering solutions to some of the most pressing global health programs. One such example is IMSCG's involvement with the Bill and Melinda Gates foundation, which the firm advised on a program to improve access to generic medication.
485 Lexington Avenue
New York, NY 10017
Employer Type: Subsidiary
Stock Symbol: IMS
Stock Exchange: NYSE
President: Jose Luis Fernandez
2014 Employees (All Locations): 475
New York, NY (HQ)
Brand & Commercial Strategy
Pricing & Market Access
Strategy & Portfolio Analysis